Stockwinners Market Radar for November 14, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:34 EST Third Point buys T-Mobile, boosts Microsoft in Q3 - Third Point disclosed in an SEC filing its holdings as of September 30, 2023. The fund's new buys during the third quarter included, by size of position, Meta Platforms (META), U.S. Steel (X), T-Mobile (TMUS), Regal Rexnord (RRX), and Telephone and Data Systems (TDS). Third Point exited its positions in Alibaba (BABA), Nvidia (NVDA), HCA Healthcare (HCA), Denbury (DEN), and Activision Blizzard (MSFT). The fund increased its stake in Microsoft, Jacobs (JEC), Uber (UBER), Option Care Health (OPCH), and Amazon (AMZN), and reduced its stake in TSMC (TSM), Alphabet Class A (GOOGL), International Flavors (IFF), DuPont (DD), and Danaher (DHR). The fund's top holdings as of September 30, in order of size, were PG&E, Microsoft, Amazon, Danaher, and Bath & Body Works (BBWI).

19:50 EST Hycroft Mining Holding Corp trading halted, news pending

19:36 EST Cedar LNG executes head sof agreement with Samsung Heavy, Black & Veatch - The Haisla Nation and Pembina Pipeline Corporation (PBA) announced the signing of a heads of agreement with Samsung Heavy Industries (SSNLF) and Black & Veatch. The HOA provides Cedar LNG, on an exclusive basis with SHI and Black & Veatch, secure access to shipyard capacity to meet Cedar LNG's target commercial operations date. The parties expect to finalize a lump sum engineering, procurement, and construction agreement in December of this year. "This exclusive relationship with SHI and Black & Veatch to lock in shipyard capacity for the construction of the Cedar LNG FLNG vessel is a major step forward for our project," said Doug Arnell, Cedar LNG Chief Executive Officer. "Through this agreement we are accessing world class expertise in the construction and delivery of floating LNG production vessels, which, together with renewable power from the BC Hydro grid, will result in an environmentally leading, state-of-the-art facility for Cedar LNG, with one of the lowest carbon footprints in the world." This agreement builds further momentum for the Project and follows receipt of all major regulatory approvals and the signing of memorandums of understanding for long-term liquefaction services with investment grade counterparties for the Project's total LNG capacity.

18:49 EST Pershing Square boosts Howard Hughes, cuts Lowe's in Q3 - Bill Ackman's Pershing Square disclosed in an SEC filing its holdings as of September 30, 2023. The fund increased its stake in three holdings, namely Alphabet Class A (GOOGL), Hilton Worldwide (HLT), and Howard Hughes (HHC). Pershing reduced its stake in one holding, namely Lowe's (LOW). The fund's top holdings as of September 30, in order of size, were Chipotle (CMG), Restaurant Brands (QSR), Hilton, Lowe's, and Howard Hughes.

18:24 EST DexCom CEO: 1 in 10 people in the world has diabetes - In an interview on CNBC's Mad Money, Kevin Sayer said continuous glucose monitoring has made people healthier and safer. He noted that when customers use GLP-1's in combination with CGMs, their results are much better. Dexcom is gaining market share both in the U.S. and abroad, he added.

18:12 EST Edgio announces $66M in new financing from Lynrock Lake Master Fund LP - Edgio announced that existing investor, Lynrock Lake Master Fund LP, has provided the company with $66M of new financing. Lynrock also exchanged its existing unsecured 3.5% convertible notes due 2025 for 3.5%/16% PIK secured convertible notes due 2027. Following these transactions, Edgio is in a stronger financial position, enabling the company to build on the solid momentum underway and continue executing its strategic plan. "We appreciate Lynrock's ongoing support and alignment with our strategy and vision. These transactions will provide us with the additional financial flexibility to expand our capabilities and scale," said Bob Lyons, President and CEO of Edgio. "Our business transformation remains on track, and we continue to execute against our key strategic objectives. We look forward to continuing to deliver world-class solutions to our customers and partners."

17:30 EST PepsiCo CFO Hugh Johnston sells over $8M in company shares - The CFO of PepsiCo, Hugh Johnston, disclosed the sale of 48,388 shares of company stock at $166.65 per share on November 10, for a total transaction amount of $8,064,068.

17:03 EST Core & Main to acquire Lee Supply Company, terms not disclosed - Core & Main has entered into a definitive agreement to acquire substantially all of the assets of Lee Supply Company Inc., a specialty distributor and fabricator of high-density polyethylene pipe and other related services, including HDPE fusion equipment rentals and custom fabrication capabilities. "Lee Supply has a distinguished history and reputation for delivering innovative solutions and providing top-quality products and services. We are confident their team members will bring industry knowledge and capabilities that will greatly enhance our HDPE product and service offerings while providing our customers with additional expertise in fusible pipe applications," said Steve LeClair, chief executive officer of Core & Main.

17:02 EST Stantec to acquire Zetcon, terms undisclosed - Stantec has signed an agreement to acquire Zetcon Engineering, a 645-person engineering firm headquartered in Bochum, Germany. The terms of the transaction are not disclosed. The firm has industry expertise in bridge certification and assessment, project and construction management of tunnels, roads, and rail infrastructure, as well as building condition assessments, improvements, and certifications.

16:48 EST FDA clears Solid Biosciences' IND for Duchenne gene therapy candidate SGT-003 - Solid Biosciences announced that it has received U.S. Food and Drug Administration FDA clearance of an Investigational New Drug IND application for SGT-003, the company's next-generation Duchenne Muscular Dystrophy Duchenne gene therapy candidate. "We are pleased to have the FDA's clearance to proceed into the clinic with SGT-003, a new, innovative gene therapy candidate for Duchenne," said Bo Cumbo, President and CEO at Solid Biosciences. "SGT-003 combines our differentiated microdystrophin transgene with a next generation muscle-tropic capsid and a transient transfection manufacturing process that may help address the unmet needs for the Duchenne community." Jessie Hanrahan Ph.D. Chief Regulatory Officer added "We appreciate the FDA's review of the IND and look forward to continuing to work in collaboration with the agency when we initiate dosing of DMD patients." SGT-003 uses a proprietary, rationally designed capsid AAV-SLB101 to deliver a DNA sequence encoding a shortened form of the dystrophin protein or microdystrophin, containing the R16 and R17 nNos binding protein domains. Preclinical data suggests this may be important for both muscular function and durability of benefit in patients. "IND clearance for SGT-003 is a critical step in bringing a potential next generation gene therapy to the clinic and making a meaningful impact on the lives of those living with Duchenne. We are working closely with clinical sites to dose the first participants, driven by the belief that better therapies are urgently required to treat this devastating disease," said Gabriel Brooks, M.D., Chief Medical Officer at Solid Biosciences. Based on the clearance, Solid plans to move expeditiously to submit the study for IRB approval at the clinical trial sites and expects to commence patient screening shortly thereafter. The planned Phase 1/2 trial, SGT-003-101, is a first in human, open-label, multicenter trial to determine the safety and tolerability of SGT-003 in pediatric patients with DMD at a dose of 1E14vg/kg. SGT-003 will be administered as a one-time intravenous infusion to patients in two cohorts with a minimum of three patients each, with the potential for cohort expansion. Cohort 1 will study patients aged 4 to less than 6 years of age with DMD. Long-term safety and efficacy will be evaluated for a total of 5 years following treatment. In an mdx mouse model of Duchenne, SGT-003 demonstrated rapid transduction, showing robust microdystrophin expression levels in the heart, quadriceps, and diaphragm by day 4 post-gene therapy treatment. SGT-003 in nonhuman primates was shown to increase biodistribution to cardiac and skeletal muscle including the diaphragm versus AAV9. These studies suggest increased transgene expression and an improved safety profile compared to first generation microdystrophin gene therapies.

16:45 EST StoneCo announces new share repurchase program of up to R$1B - StoneCo announced that its Board of Directors, pursuant to written resolutions dated November 9th, 2023, has authorized a share repurchase program, under which Stone may repurchase up to R$1B in outstanding Class A common shares. This new share repurchase program is a replacement to the previous share repurchase program announced by Stone on October 3rd, 2023. Under the former program, Stone repurchased a total of 5,733,740 shares on an average price of $10.29 per share, with a total amount of $59M. The new repurchase program will be effective with timing of the full amount to be repurchased to be determined after further consultation with the Board. The program approved does not have a fixed expiration date.

16:43 EST Frequency Electronics announces contract award for approximately $25M - Frequency Electronics announces a contract award of approximately $25m to deliver precision frequency-generation systems for a next generation national security satellite program. Under this contract, FEI will develop, manufacture, test and deliver a state-of-the-art frequency generation system to the prime contractor for integration into satellites. The hardware will provide the primary frequency reference for the spacecraft and enhance its mission effectiveness. As an important aspect of this program, FEI is targeted to deliver all the contracted hardware within a period of less than 24 months. This is part of an on-going effort to demonstrate the ability to deliver space hardware faster, in support of the US government goal of achieving a more resilient space presence. This high-performance, space qualified system is an evolution of FEI's technology which has been proven on numerous US government and commercial satellite programs over the last 62 years. Tom McClelland, FEI CEO, commented, "We are very excited and well prepared to get started on this important space program, and are committed to delivering hardware that meets or exceeds requirements, on or ahead of schedule. We believe this significant award is a good example of the type of next-generation systems we have been working on, and is illustrative of why we are so optimistic about our future growth trajectory."

16:39 EST Truist Financial announces leadership appointments - Truist Financial announced continued progress in the company's transformation journey with the creation of a COO position, the naming of a new chief consumer & small business banking officer and the hiring of a new chief wholesale banking officer. Truist Vice Chair Beau Cummins will assume the COO role immediately. His responsibilities in this new role include leading enterprise strategy, transformation, operations, and payments as well as a new governance and controls group. Since 2021, Cummins has served as vice chair with responsibility for Truist's corporate and investment banking, commercial real estate, wealth, and national consumer finance services and payments businesses, in addition to Truist's corporate strategy and enterprise operations. He previously served as head of Truist's corporate and institutional group. Donta Wilson has been named chief consumer & small business banking officer. He is responsible for the consumer, premier, and small business segments serving clients through mobile and online banking, multiple virtual client service centers and more than 2,000 community banking branches across the Southeast, Mid-Atlantic, and Texas. Kristin Lesher will be the new chief wholesale banking officer, overseeing corporate and investment banking, commercial banking, commercial real estate, and wealth management businesses. She comes to Truist from Wells Fargo, where she has held key leadership positions for more than two decades, most recently serving as executive vice president and head of commercial banking coverage. The three roles report directly to Chairman & CEO Bill Rogers.

16:37 EST Eli Lilly receives NRC consent regarding proposed Point Biopharma acquisition - Eli Lilly and Company (LLY) announced that the U.S. Nuclear Regulatory Commission has issued its consent for the indirect transfer of control of Point Biopharma Global's (PNT) radioactive materials license, which will occur following the completion of Lilly's previously announced tender offer to acquire all of the issued and outstanding shares of common stock of POINT, for a purchase price of $12.50 per share in cash, without interest and less any applicable tax withholding. Obtaining the NRC Consent is the last regulatory approval necessary for the consummation of the transaction. The tender offer is scheduled to expire at 5:00 p.m., Eastern time, on Nov. 16, 2023, unless the tender offer is further extended or earlier terminated.

16:32 EST Granite announces ARC awarded contract by Caltrans for CM/GC project - Granite announced that the American River Constructors, ARC, joint venture team comprised of Granite and California Engineering Contractors has been awarded another contract by the California Department of Transportation, Caltrans, for the American River Bridge Rehabilitation Construction Manager/General Contractor, CM/GC project in Sacramento, California. A CM/GC Preconstruction Service contract has been underway since January 2021 and was recently completed. In addition, three child contracts totaling $70 million have been executed for access, clearing, steel piling and girder procurement, and bridge substructure construction. The newest contract is a $131 million parent project contract to construct the superstructure for the replacement of the existing bridge deck in three stages. The contract was included in Granite's second-quarter 2023 CAP and is slated for completion in the first quarter of 2026. "The ARB Project Team has done an amazing job of working together to deliver these child projects, including weathering the unprecedented storms from multiple atmospheric rivers last winter," said George Delano, Granite project executive. "We have hit the ground running on this final Parent Project and will have the girders erected before Thanksgiving. We look forward to a very successful project."

16:25 EST Fannie Mae announces leadership changes - Fannie Mae announced a series of leadership changes following decisions by two veteran executives that they will soon retire from the company. President David C. Benson announced that he will retire in early to mid-2024 after 21 years of serving in a wide range of positions, including Interim CEO, CFO, Executive Vice President - Capital Markets, and Treasurer. In addition, Chief Administrative Officer Jeffery Hayward announced his intention to retire as of December 31, after 36 years with Fannie Mae during which he also led the company's Multifamily business and its National Servicing Organization. Upon Benson's departure, CEO Priscilla Almodovar, who joined the company last year, will assume the additional title of President. In this expanded capacity, she will directly manage the company's two business units: Single-Family, led by Executive Vice President Malloy Evans, and Multifamily, led by Executive Vice President Michele Evans.Current General Counsel Terry Theologides will succeed Hayward as Chief Administrative Officer. The company also announced that Danielle McCoy will become the new General Counsel & Corporate Secretary. McCoy currently serves as Senior Vice President, Deputy General Counsel & Deputy Corporate Secretary. Terry Theologides has been General Counsel & Corporate Secretary for more than four years and previously served in senior roles at CoreLogic, Inc. and Morgan Stanley's mortgage businesses. As Chief Administrative Officer he will be responsible for a broad range of Fannie Mae's operations.

16:17 EST Ocean Power announces plan to achieve profitability in calendar year 2025 - Ocean Power Technologies announced several milestones and initiatives it believes will enhance shareholder value, including: OPT is divesting its non-core strategic consulting team; With its research and development phase substantially completed, the Company now expects to achieve profitability in calendar year 2025; Matt Burdyny has been appointed to the newly created role of Chief Commercial Officer to drive commercialization efforts that will support OPT's financial goals. OPT CEO and President Dr. Philipp Stratmann commented: "As we have consistently stated, we are seeing meaningful progress in orders, pipeline, and backlog across our business, especially with the completion of our product development efforts. Despite current economic headwinds, we have built a cutting-edge suite of products that we believe will be the basis for our current and future commercial success and that will help drive profitability in calendar year 2025. Matt's promotion to the newly created Chief Commercial Officer role aligns with our strategy of focusing on meeting our customers' needs and emphasizing commercialization as we move away from the R&D phase of our evolution. Our focus remains first and foremost on executing our strategy in order to generate value for our shareholders."

16:11 EST Paragon 28 launches BEAST Cortical Fibers - Paragon 28 announced the launch of its BEAST Cortical Fibers which provide an osteoinductive porous structure for cellular attachment and an osteoinductive potential to aid in cellular differentiation and bone formation. These loose cortical fibers are engineered to complement specific surgical applications in the foot and ankle and are flexible upon hydration allowing for application even in extremely challenging fusion locations. The cortical matrix absorbs bioactive fluid including bone marrow aspirate and supports cellular infiltration to drive efficient bone remodeling. Powerful processing capability allows for preservation of native bone morphologic proteins and other growth factors necessary for the promotion of bone formation.

16:08 EST Sarcos Technology plans AI software platform to launch by mid-2024 - Sarcos's vision for its AI software platform began in 2017 and progressed to its first CYTAR government proposal in 2019. Significant design and development work began in 2020 when Chief Technology Officer Dr. Denis Garagi joined the Company. AI software development contracts with the U.S. Air Force provide funding for the development of the AI software platform and opportunities to test the platform in real-world use cases. Sarcos anticipates bringing a version of its AI software platform, compatible with most industrial robots being sold today, to market in the first half of 2024. A subsequent version with additional features is planned for release by the end of 2024.

16:04 EST SEC says Charter to pay $25M penalty for unauthorized stock buybacks - The Securities and Exchange Commission announced settled charges against Charter Communications Inc. for violating internal accounting controls requirements when it engaged in stock buybacks not authorized by its board of directors. According to the SEC's order, Charter's board authorized company personnel to conduct certain buybacks using trading plans that conform to SEC Rule 10b5-1. The SEC's order finds that, from 2017 to 2021, Charter used plans that included "accordion" provisions, which company personnel described as giving Charter flexibility, that allowed Charter to change the total dollar amounts available to buy back stock and to change the timing of buybacks after the plans took effect. According to the SEC's order, because Charter's trading plans did not meet the conditions of Rule 10b5-1, the company's buybacks did not comport with the board's authorizations. The SEC's order finds that Charter included accordion provisions in nine separate trading plans over the four-year period. The SEC's order finds that Charter violated Section 13(b)(2)(B) of the Exchange Act. Without admitting or denying the findings in the order, Charter agreed to cease-and-desist from further violations of Section 13(b)(2)(B) and pay a civil penalty of $25M. Reference Link

15:46 EST Ispire Technologiy Inc trading resumes

15:40 EST Chase Coleman's Tiger Global buys Elastic, exits Dlocal in Q3 - Chase Coleman's Tiger Global disclosed in an SEC filing its holdings as of September 30, 2023. The fund's new buys for the third quarter included, by size of position, Elastic (ESTC), PDD (PDD), Alibaba (BABA), DoorDash (DASH), and Procore (PCOR). Tiger exited two positions during the quarter, including by size of previous position Dlocal (DLO) and Katapult (KPLT). The fund increased its stake in Sea Ltd. (SE), Alphabet Class A (GOOGL), Nvidia (NVDA), Meta Platforms (META), and Workday (WDAY), and reduced its stake in JD.com (JD), Intuit (INTU), Kanzhun (BZ), Pagaya (PGY), and ServiceNow (NOW). Tiger's top holdings as of September 30, in order of size, were Meta, Microsoft (MSFT), Apollo Global (APO), Take-Two (TTWO), and Alphabet Class A.

15:26 EST Livent, Allkem receive all regulatory approvals for merger - Livent announced that Arcadium Lithium plc, the new holding company of the combined group that will result from the proposed merger of Allkem and Livent, has now received all required pre-closing regulatory approvals in connection with the proposed merger of equals between Allkem and Livent. This includes antitrust approvals in Canada, China, Japan, South Korea and the U.S., as well as completion of investment screenings in Australia, the U.K. and the U.S. Allkem and Livent are targeting closing of the Transaction on January 4, 2024. The closing of the Transaction remains subject to approval by both Livent and Allkem shareholders, and Australian Court approval of the Scheme.

14:39 EST Coinbase investigating elevated error rates - In a status message posted to its site, Coinbase stated: "We're currently investigating elevated error rates across Coinbase.com (web and mobile). Customers may have trouble trading or completing a buy/sell. Rest assured funds are safe and we're working to fix ASAP. We'll update you here shortly." Reference Link

14:04 EST Juniper SVP sees trajectory in enterprise as 'sustainable' - Juniper's Kevin Hutchins, SVP of Strategy, said while presenting at the Needham Virtual Security, Networking and Communications Conference, according to a transcript of the event: "So for us, I think you know, at least in this last quarter and then as we look into Q4 and into 2024 for the demand side drivers on the enterprise side look look pretty positive for us and don't seem to be conveying a similar story with regards to, you know, a potential kind of dip. So I do feel pretty confident right now that, you know, our the trajectory that we have in enterprise is sustainable."

12:37 EST Rebag announces partnership with ThredUP - Rebag announced a "multifaceted partnership" with thredUP, via which Rebag customers can now resell gently-worn items on thredUP for Rebag shopping credit, and thredUP customers can shop select Rebag inventory directly on thredup.com. "Industry collaboration is key to building a more sustainable future for fashion, and Rebag and thredUP have a shared vision around reuse's ability to reduce fashion's impact. Through our partnership, we're enabling more shoppers to participate in resale and ultimately encouraging people to make more sustainable shopping choices," said James Reinhart, CEO of thredUP.

12:00 EST Debt Resolve falls -18.0% - Debt Resolve is down -18.0%, or -$10.61 to $48.41.

12:00 EST Fisker falls -22.5% - Fisker is down -22.5%, or -93c to $3.19.

12:00 EST First Foundation rises 23.7% - First Foundation is up 23.7%, or $1.21 to $6.31.

11:47 EST Airbnb acquires 'stealth 12-person AI company' GamePlanner.AI - Airbnb announced it has acquired GamePlanner.AI, a stealth 12-person AI company led by Adam Cheyer and Siamak Hodjat. "What makes GamePlanner.AI so special is that they combine expertise in AI, design, and community. AI will rapidly alter our world more than any other technology in our lifetime, but we need to ensure that it augments humanity in a positive way. Airbnb is one of the more humanistic companies in technology, and I believe that, together with Adam and his team, we can develop some of the best interfaces and practical applications for AI," said Airbnb CEO and co-founder Brian Chesky. Reference Link

11:12 EST Precipio trading resumes

11:01 EST Celsius drops after Morgan Stanley highlights cooling scanner data - The shares are down 7% to $150.46 in morning trading.

10:31 EST Air T trading halted, volatility trading pause

10:29 EST reAlpha Tech Corp trading resumes

10:19 EST reAlpha Tech Corp trading halted, volatility trading pause

10:02 EST TC Biopharm announces completion of safety cohort, DSMB results - TC BioPharm announced that it has successfully completed its Safety Cohort and received positive review from the Data Safety Monitoring Board. The DSMB review was held after completion of enrollment of the initial cohort of the ACHIEVE trial and examined the safety data from all patients enrolled to ensure of no dose limiting toxicities or drug related serious adverse events. TC BioPharm's trial involves administering TCB008, dubbed OmnImmune in the UK, to treat Acute Myeloid Leukemia in a large swathe of patient population. Management now intends to move the ACHIEVE Trial forward with enrollment and will continue dosing patients for the phase 2B clinical trial beginning in 2024, with an additional 14 patients to be dosed prior to an interim look at data. TC BioPharm expects to propose amendments to the existing protocol of ACHIEVE to better align ACHIEVE and ACHIEVE 2 protocols in dosing and other areas in an effort to generate a more heterogeneous data set across trials. "This positive safety review marks an important milestone in the development of our allogeneic gamma delta platform, building on the strong safety profile that we previously established for our novel therapeutic," said Bryan Kobel, CEO of TC BioPharm. "We expect the trial to enroll well in 2024, as we believe there is a high degree of interest in our therapeutic and a growing recognition of the role gamma deltas play in the fight against cancer. We will begin redosing in ACHIEVE based on the compelling existing therapeutic profile. While the process has been relatively slow getting to this point in ACHIEVE, we believe those headwinds to have subsided and been addressed by our team and we look forward to a more rapid open enrollment throughout 2024 now that the safety portion of the trial is complete."

10:00 EST Debt Resolve falls -12.3% - Debt Resolve is down -12.3%, or -$7.27 to $51.75.

10:00 EST Fisker falls -14.9% - Fisker is down -14.9%, or -61c to $3.50.

10:00 EST Anywhere Real Estate rises 16.3% - Anywhere Real Estate is up 16.3%, or 72c to $5.14.

09:59 EST Home Depot says supply chains 'operating very well' - Says operations "getting back to normal." Says inventory positions are better. Says in-stock rates "much better." Says wage investments "paying off." Says employee attrition "way down." Says customer "still very resilient." Says worst of inflationary environment "behind us." Expects "slight pressure" on gross margin y/y. Says has seen inflation abate across portfolio. Says "no change" in capital allocation stance. Says "focused" on Pro ecosystem.

09:54 EST HNR Acquisition Corp trading resumes

09:47 EST Daily S&P Biotech Bear 3x Shares falls -11.9% - Daily S&P Biotech Bear 3x Shares is down -11.9%, or -$2.94 to $21.72.

09:47 EST Fisker falls -20.4% - Fisker is down -20.4%, or -84c to $3.27.

09:47 EST Paysafe rises 14.5% - Paysafe is up 14.5%, or $1.55 to $12.25.

09:39 EST HNR Acquisition Corp trading halted, volatility trading pause

09:30 EST VivoPower announces 'sum of the parts' strategic value maximization review - VivoPower International has announced that it has initiated a sum of the parts strategic value maximisation review in relation to the Company and has engaged a corporate adviser, Chardan, in this regard.The strategic review has been prompted by inbound expressions of interest for both Tembo and Aevitas Kenshaw over the past few weeks. These transactions are currently in the due diligence phase and hence may not culminate in definitive agreements. As a B Corporation, the VivoPower board is mindful of its fiduciary duties to maximise value for stakeholders, including shareholders. It remains committed as part of this strategic review process to delivering on the B Corp triple bottom line of people, profit and planet.

09:23 EST Home Depot sees FY23 operating margin 14.1%-14.2%; FY23 tax rate 24.5%

09:21 EST Home Depot reports Q3 gross margin 33.8%, down 20 bps y/y - Says Q3 gross margin "in-line with expectations."

09:16 EST Matterport, Belden enter global alliance to digitize built environments - Matterport (MTTR) and Belden (BDC) have announced a new partnership intended to deliver 3D digital twin-powered connectivity solutions for facilities management across industrial automation, smart buildings, broadband and more. Through this agreement, Matterport will become a part of Belden's edge-to-cloud solution stack, bringing the visualization, spatial data and developer tools of Matterport's 3D digital twins to Belden's secure data acquisition, transmission, orchestration and management services. With both companies a part of the Amazon Web Services Partner Network, Matterport and Belden will also work closely with the leading cloud provider to deliver new solutions that support customers throughout their operational transformation efforts.

09:14 EST XBiotech announces Kivitz is now Lead Investigator, Study Chairman - XBiotech announced that Alan Kivitz M.D. is now Lead Investigator & Study Chairman for its clinical research program for Natrunix in Rheumatoid Arthritis. XBiotech believes Natrunix will be a breakthrough therapy for rheumatological diseases.

09:12 EST Home Depot says Pro customer outperformed DIY in Q3 - Says "investing in a multitude of initiatives" for Pro's. Says Pro's are "one of the biggest growth opportunities" for the company. Says has "relatively little share" of the Pro market. Comments taken from Q3 earnings conference call.

09:11 EST Cuentas releases proposed acquisition of majority stake in WHEN - Cuentas shares specifics on its recently executed binding letter of intent with WHEN Group, a developer of an alternative financial ecosystem for underbanked communities. The proposed share exchange transaction, pending Nasdaq and shareholder approval and other specified conditions, will result in WHEN Group becoming a majority-owned subsidiary of Cuentas. WHEN has been developing solutions that utilize advanced pattern recognition and AI to create a security screening environment that can detect and defend against a range of threats and attacks on telecom, banking, and other communication infrastructure. Cuentas intends to integrate WHEN's portfolio of cybersecurity solutions into the Cuentas Mobile product. In consideration for the principal shareholder of WHEN, UCG exchanging its 75% stake, Cuentas will issue to UCG a number of common shares of CUEN which will represent, on the date of issuance, 50% of Cuentas' issued and outstanding capital. Following the closing, WHEN will be a majority-owned subsidiary of Cuentas. The executive management of WHEN will develop a detailed and granular business plan and operating budget. "I've had longstanding connections with several members of the WHEN Group team and have consistently held the conviction that their innovative solutions could set a new standard in communication security for both businesses and families," stated Arik Maimon, the co-founder and CEO of Cuentas. "In the current climate, the developments underway at WHEN are more crucial than ever, and we stand ready to contribute to bringing their solutions to our growing customer base."

09:10 EST Udemy, McLaren Racing announce multi-series partnership - McLaren Racing and Udemy announced a multi-year partnership spanning the full McLaren physical racing portfolio. In a first-of-its-kind partnership, Udemy, a leading online skills marketplace and learning platform, will become the Official Learning and Skills Partner of McLaren Racing, including the McLaren Formula 1 Team, Arrow McLaren IndyCar Team, NEOM McLaren Formula E Team and NEOM McLaren Extreme E Team. Greg Brown, President and CEO, Udemy, said: "We are excited to partner with McLaren Racing to develop their team, from those in the driver's seats and pit lanes to those running the business in their corporate offices. Udemy's fresh and relevant course content will help McLaren maintain a high-performing team, staying ahead of fast-moving and ever-evolving trends in technology and business. We're equally thrilled to support all four physical race series, demonstrating our commitment to the McLaren team's learning journey."

09:08 EST Fat Brands announces six new Texan locations - FAT Brands Inc., parent company of Fatburger and 17 other restaurant concepts, announces a new development deal set to bring six additional franchised Fatburger locations to Hidalgo County, Texas in the next five years. The news comes on the heels of the recent opening of the first co-branded Fatburger and Round Table Pizza restaurant in Lantana, Texas. "The Fatburger brand continues to expand in Texas," said Taylor Wiederhorn, Chief Development Officer of FAT Brands. "Fatburger has a pipeline of approximately 50 restaurants to be built in Texas alone and the franchisee demand to develop more Fatburger restaurants throughout the state has not slowed down. We look forward to adding six more restaurants to our existing development pipeline in Texas with further growth near the southern border."

09:07 EST Charles Schwab reports client assets $7.65T up 9% YoY - The Charles Schwab Corporation released its Monthly Activity Report today. Company highlights for the month of October 2023 include: Core net new assets brought to the company excluding Ameritrade brokerage originated clients equaled $16.1B for the month, while total core net new assets across all clients totaled $11.3B in October. These flows reflect expected attrition from former Ameritrade clients as well as delayed tax disbursements by clients in certain states such as California. Total client assets were $7.65 T as of month-end October, up 9% from October 2022 and down 2% compared to September 2023. Client cash on the balance sheet plus bank deposit account balances ended the month at $397.9 B, as client tax disbursements and seasonal advisory fee payments influenced the October trend. Equaling 5.2% at October month-end, the ratio of transactional sweep cash to total client assets has remained relatively stable since July.

09:06 EST Lightspeed Commerce selected by David Jones - Lightspeed Commerce has been selected by David Jones as part of its Vision 2025+ strategy to digitize its merchandising and buying process. Launching in January with the women's international and designer ready-to-wear categories, David Jones will utilize NuORDER Assortments to digitally preview collections, curate assortments and complete orders in collaboration with their brands. This partnership will accelerate David Jones' digital transformation efforts and replace manual, time consuming processes like data collection, sizing and order writing.

09:04 EST Lazydays and Bowlus announce exclusive national partnership - Lazydays announced its exclusive national partnership with Bowlus, a company providing luxury recreation vehicles. Bowlus is opening five new dealerships: Bowlus of Denver at Lazydays, Colo., Bowlus of Houston at Lazydays, Texas, Bowlus of Knoxville at Lazydays, Tenn., Bowlus of Tampa at Lazydays, Fla., and Bowlus of Vancouver at Lazydays, Wash. All five Bowlus locations will offer the full range of Bowlus RVs. Lazydays will be the exclusive dealer of Bowlus RVs nationwide, with further expansion plans scheduled for 2024.

09:02 EST Iveda Solutions delivers on $200,000 contreact with Waymark Gardens - Iveda announced that Movement Interactive, powered by Iveda, has delivered on a $200,000 contract with Waymark Gardens, effectively supporting hundreds of residents aging in place with AI and IoT-enabled telehealth and fall detection technology. By delivering IvedaAI appliance hardware and software as well as 150 HIPAA-compliant IvedaCare kits, outfitted with IvedaAI and Iveda's proprietary IoT-enabled sensors and devices, the contract will support the ongoing care and safety of patients residing within Waymark Gardens' facilities.

08:41 EST Mama's Creations appoints Blake to board of directors - Mama's Creations announced the appointment of veteran finance leader Lynn Blake to its Board of Directors. Lynn will also serve as Chair of the Board's Audit Committee. Lynn brings over 30 years of financial leadership and public market experience to the Mama's Creations Board, including Chief Financial Officer experience at multiple publicly traded companies, a private equity-owned portfolio company, and a venture-backed startup.

08:40 EST Nano Dimension announces breakthrough in materials for AME - Nano Dimension announced a breakthrough in the development of a material that is a critical enabler for the advancement of additively manufactured electronics. Yoav Stern, Chief Executive Officer and a member of the Board of Directors of Nano Dimension, added: "We are proud to share this breakthrough in materials with our customers and the industry. When we set out a strategic plan in 2021, materials development was a core focus for our R&D team. The reality of additive manufacturing is that no matter how good the printer may be, materials must also be leading. This development achieves just that with improved functionality and critical industry standard adherence without which wider adoption would be greatly limited."

08:39 EST Bitcoin Depot named preferred BTM Vendor with AATAC - Bitcoin Depot announced it has been named a preferred vendor with the AATAC, a national trade association of retailers, distributors, vendor suppliers and partners for the convenience store and retail industries. Bitcoin Depot is the first BTM company to have gained recognition as a preferred vendor for AATAC, strengthening Bitcoin Depot's value proposition. "Bitcoin Depot is proud to work with the AATAC as the association's preferred BTM vendor, which introduces our company to AATAC's 50,000 associated retailers nationwide," said Bitcoin Depot CEO Brandon Mintz. "This is another milestone in our mission to bring Bitcoin to the masses."

08:39 EST Hoth Therapeutics completes pre-IND meeting with FDA on HT-KIT in cancer - Hoth Therapeutics announced the successful completion of a pre-IND meeting with the FDA regarding the company's development plan for its HT-KIT therapeutic. The Pre-IND meeting was completed through written responses provided by the FDA Nonmalignant Hematology Division of Regulatory Operations for Cardiology, Hematology, Endocrinology, and Nephrology. HT-KIT is an antisense oligonucleotide that targets the proto-oncogene cKIT by inducing mRNA frame shifting and already has Orphan Drug Designation from the FDA. Hoth is developing the drug product HT-KIT indicated for the treatment of adult patients with AdvSM. HT-KIT is a single-strand phosphorodiamidate morpholino oligonucleotide. The purpose of the requested meeting was to gain the Agency's agreement on the suitability the 505(b) regulatory pathway for approval of HT-KIT; adequacy of referenced nonclinical information and the proposed drug development plan to support opening the IND; and to discuss any filing issues the Agency may have with the proposed product. The Sponsor was granted Orphan Drug Designation for HT-KIT for the treatment of mastocytosis. Based on the FDA's feedback, Hoth intends to advance its IND-enabling activities for HT-KIT as planned.

08:32 EST Wiley to sell University Services segment to Academic Partnerships - Wiley and Academic Partnerships, a company that assists primarily regional public universities in expanding access and impact by supporting their online programs, has entered into a definitive agreement to acquire Wiley University Services, a line of business owned by Wiley. The combined company will support over 125 colleges and universities in 40 U.S. states and internationally. AP primarily assists regional public universities with launching and maintaining their online programs. The transaction is expected to close by early 2024, subject to regulatory approvals and the satisfaction of customary closing conditions.

08:21 EST Society Pass applies to extend an additional 180 days to meet minimum bid price - Society Pass announces that it has applied to The Nasdaq Stock Market requesting an additional 180 days to comply with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). With the exception of the bid price requirement, SoPa believes it meets the continued listing requirements for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market including stockholders' equity, publicly held shares, public holders and market makers.

08:19 EST Hess: Prosperity to reach its initial production of 220K gross BPD over 1H24 - Hess announced startup of production from the Payara development on the Stabroek Block offshore Guyana, utilizing the Prosperity floating production, storage and offloading FPSO vessel. The Prosperity is expected to reach its initial production of 220,000 gross barrels of oil per day over the first half of 2024 as new wells are brought online. Production capacity on the Stabroek Block is now approximately 620,000 gross barrels of oil per day. The Prosperity FPSO arrived in Guyana in April 2023. It is moored in water depth of about 6,300 feet and will develop an estimated resource base of more than 600 million barrels of oil. "We are proud to be a partner in the successful development of this world class oil resource for the benefit of the people of Guyana and all other stakeholders and congratulate ExxonMobil as operator for outstanding project execution," CEO John Hess said. "The world will need these low cost oil resources to meet future energy demand and help ensure an affordable, just and secure energy transition." The Stabroek Block is 6.6 million acres. ExxonMobil Guyana Limited is operator and holds 45% interest in the Stabroek Block. Hess Guyana Exploration Ltd. holds 30% interest and CNOOC Petroleum Guyana

08:17 EST Verisk Analytics expands collaboration with NFPA - Verisk has expanded its collaboration with the National Fire Protection Association, NFPA, to provide wildfire risk and mitigation data from its Firewise USA recognition program to 12 additional states in the western U.S. Verisk first collaborated with NFPA in 2020 and has continued to foster that relationship over the years. In 2021, Verisk began leveraging data from NFPA's Firewise USA Program, which tracks thousands of communities engaging in wildfire mitigation efforts. Verisk uses that dataset for property-level analytics that insurers can use to refine underwriting and support carriers' needs for regulatory compliance resources. Through this extended agreement, Verisk will now expand its license from California to mitigation insights for the remaining western coverage states, including Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Oklahoma, Oregon, Texas, Utah, Washington, and Wyoming.

08:15 EST Apollo Global, CATEC launch Hydria through acquisition of Kelley Leasing - Apollo and Composite Advanced Technologies, CATEC, announced that CATEC, an affiliate of Apollo-managed funds has acquired Kelley Leasing Partners, a compressed gas and cryogenic liquid transportation equipment leasing company serving hydrogen, helium and CNG customers across industrial gas, utility and virtual pipeline end markets. In connection with the acquisition, Apollo Funds and CATEC have launched Hydria, a high-growth compressed gas platform providing equipment and services supporting the CNG, RNG, helium and hydrogen value chain with over-the-road transport, storage and leasing capabilities. Apollo Funds are the majority owner of Hydria.

08:13 EST Splunk announces expiration of Hart-Scott-Rodino period for Cisco transaction - Splunk (SPLK) announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the previously announced agreement for Splunk to be acquired by Cisco ( CSCO) for $157 per share in cash. The expiration of the waiting period under the HSR Act occurred at 11:59 p.m. Eastern Time on November 13 . The completion of the merger remains subject to the satisfaction of other closing conditions specified in the merger agreement, including approval of the merger under other applicable antitrust and foreign investment laws and approval by Splunk stockholders. Splunk continues to expect to complete the merger by the end of the third calendar quarter of 2024.

08:12 EST Talis Biomedical announces exploration of strategic alternatives - Talis Biomedical announced it has initiated a process to explore strategic alternatives with the goal of maximizing shareholder value. While the Company has made progress developing the Talis One system, it believes that this is a prudent path forward given current market conditions. As part of this process, the Company's Board of Directors has appointed a special committee of independent, disinterested directors to consider a wide range of strategic alternatives, including, but not limited to, equity or debt financing alternatives, an acquisition, merger, reverse merger, divestiture of assets, licensing or other strategic transactions. There can be no assurance that the ongoing strategic review will result in Talis Biomedical entering into any transaction or that any transaction will be completed on attractive terms. The Company has not set a timetable for completion of the strategic process and does not intend to provide progress updates unless and until it is determined that further disclosure is appropriate or necessary.

08:09 EST Exxon Mobil starts production at Payara offshore Guyana project - ExxonMobil (XOM) started production at Payara, Guyana's third offshore oil development on the Stabroek Block, bringing total production capacity in Guyana to approximately 620,000 barrels per day. The Prosperity floating, production, storage and offloading, or FPSO, vessel is expected to reach initial production of approximately 220,000 barrels per day over the first half of next year as new wells come online. This additional capacity will be the third major milestone towards reaching a combined production capacity of more than 1.2M barrels per day on the Stabroek Block by year-end 2027. ExxonMobil Guyana anticipates six FPSOs will be in operation on the Stabroek Block by year-end 2027. Yellowtail and Uaru, the fourth and fifth projects, are in progress and will each produce approximately 250,000 barrels of oil per day. The company is working with the government of Guyana to secure regulatory approvals for a sixth project at Whiptail. Prosperity joins the Liza Unity as two of the world's first FPSOs to be awarded the SUSTAIN-1 notation by the American Bureau of Shipping in recognition of the sustainability of its design, documentation and operational procedures. ExxonMobil's Guyana developments are generating around 30% lower greenhouse gas intensity than the average of ExxonMobil's upstream portfolio. According to the independent research firm Rystad Energy, they are also among the best performing in the world with respect to emissions intensity, outpacing 75% of global oil and gas producing assets. ExxonMobil Guyana operates the Stabroek Block and holds 45% interest. Hess Guyana Exploration (HESM) holds 30% interest, and Cnooc (CEO) holds 25% interest.

08:07 EST Assertio Holdings appoints Emany to its board of directors - Assertio announced that Sravan Emany has been appointed to the Company's Board of Directors. As part of the appointment, Assertio has expanded its board to seven seats. Emany currently serves as the Chief Financial Officer of Ironwood Pharmaceuticals.

08:04 EST Agilent receives FDA approval for PD-L1 IHC 22C3 pharmDx - Agilent announced that it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Gastric or Gastroesophageal Junction, or GEJ, Adenocarcinoma who may be eligible for treatment with Keytruda, Merck's anti-PD-1 therapy. PD-L1 IHC 22C3 pharmDx is the only FDA-approved companion diagnostic that can identify gastric or GEJ adenocarcinoma patients suitable for treatment with Keytruda in combination with chemotherapy and trastuzumab plus fluoropyrimidine. This marks the sixth cancer type for which PD-L1 IHC 22C3 pharmDx has gained FDA approval.

08:02 EST RedHill Biopharma to transfer listing to Nasdaq Capital Market - RedHill Biopharma announced that it has received approval from the Listing Qualifications Department of The Nasdaq Stock Market to transfer the listing of the American Depositary Shares to the Nasdaq Capital Market. The ADSs will be transferred to the Nasdaq Capital Market at the opening of business on November 15. Trading of RedHill ADSs will be unaffected by the transfer, with no break in trading, and will continue under the same ticker symbol of "RDHL" and utilizing the existing CUSIP number.

08:00 EST Middlefield Banc announces Zimmerly to succeed Heslop as CEO - Middlefield Banc announced the Company has appointed Ronald Zimmerly, Jr. as Chief Executive Officer, succeeding James Heslop, II. Zimmerly, currently President and Director of Middlefield Banc and The Middlefield Banking Company, will assume the role of Chief Executive Officer of both entities on January 1, 2024, upon Heslop's retirement. Heslop will resign from the Middlefield Banc Corp. Board of Directors on December 31, 2023. The Company's Board of Directors has taken action to reduce the size of its Board of Directors from 13 to 12 effective on December 31, 2023. Zimmerly joined Middlefield as President following the acquisition of Liberty Bancshares, Inc. on December 1, 2022.

07:49 EST Lincoln Electric appoints Hall as Senior Vice President, Global Procurement - Lincoln Electric announced that J. Ashley Hall has joined the Company to serve as Senior Vice President, Global Procurement, effective immediately. In this new role, Hall will oversee global procurement as a member of the executive leadership team and will report to Steven B. Hedlund, Executive Vice President, Chief Operating Officer, who will be promoted to the position of Chief Executive Officer beginning January 1, 2024.

07:47 EST F9 Investments proposes to acquire LL Flooring for $3.00 per share - F9 Investments which, together with its affiliates, collectively owns approximately 8.8% of LL Flooring's common stock, sent a letter to the board of directors of LL Flooring proposing to acquire all the issued and outstanding shares of common stock of LL Flooring for $3.00 per share. The proposed offer is not subject to any financing condition and is fully financed through cash on hand and borrowing under an existing revolving credit facility from an affiliate of F9. F9's owner, Thomas Sullivan said, "We believe our offer represents a compelling, immediate, and certain cash value for LL's shareholders, in light of the Company's deteriorating financial condition and declining stock price, which in our view reflects the market's lack of confidence in the current Board's strategy. LL Flooring's most recent, dismal third quarter earnings performance further reflects the Board and management's lack of urgency, credible plan, execution ability, or capacity to control costs despite numerous pledges to do so."

07:46 EST Intellia Therapeutics receives European Union ODD for NTLA-2002 - Intellia Therapeutics announced that the European Commission, EC, has granted orphan drug designation, ODD, to NTLA-2002 for the treatment of hereditary angioedema, HAE. NTLA-2002 is an in vivo CRISPR-based investigational therapy designed to prevent potentially life-threatening swelling attacks in people with HAE. "The European Union orphan drug designation for NTLA-2002 represents another important milestone for Intellia as we continue to make rapid progress in the development of a novel, potential one-time treatment for people with hereditary angioedema," said Intellia President and Chief Executive Officer John Leonard, M.D. "We are on track to complete enrollment of the Phase 2 portion of the study in the coming weeks, which will bring us one step closer to our goal of delivering a potentially life-changing treatment for people who suffer from this serious and debilitating disease."

07:40 EST Bread Financial reports October net loss rate 8% vs 6.1% last year - Reports October delinquency rate 6.5 % vs. 5.4% last year...

07:33 EST GreenPower Motor receives orders for 35 orders for electric buses in California - GreenPower Motor announced orders for 35 Type D all-electric, purpose-built school buses for the California market. GreenPower received the orders from its exclusive California dealer Model 1 - formerly Creative Bus Sales - for 25 of the Mega BEAST school buses for the Montebello School District and 10 BEAST school buses for the Garden Grove school district. Funding for the all-electric, zero-emission school buses comes from both the California HVIP program and the EPA Clean School Bus Program. In the past month, California Governor Gavin Newsom signed legislation requiring all new school buses in California be electric by 2035. GreenPower's BEAST is a 40-foot Type D all-electric, purpose-built, zero-emission school bus. The Mega BEAST, introduced on October 31st, delivers a range of up to 300 miles on a single charge via a 387 kWh battery pack.

07:31 EST Nevada Copper provides updates from Pumpkin Hollow mine - Nevada Copper provides updates on recent operational developments at its Pumpkin Hollow underground mine, including the first deliveries of concentrate in October 2023. Randy Buffington, President and CEO of Nevada Copper, stated, "The mill has been able to process at nameplate capacity for certain periods exceeding expected recoveries on a number of occasions. With additional refinement, we expect to be achieving nameplate capacity consistently by the end of 2023 meeting all expected operating parameters. The team has worked tirelessly to get us to this point and I appreciate their dedication towards the restart and ramp up of the mine."

07:30 EST Osino Resources provides update on Phase 2 drill program at Eureka Project - Osino Resources provides an update on the Phase 2 drill program at the Eureka Project. This current drill program is aimed at further definitng and expanding the Eureka godl discovery announced in the news release dated 9th August 2023. Dave Underwood, Osino's VP Exploration commented: "We have now spent considerable time and effort on site doing fine-scale mapping and relogging core to interpret the results at this first Eureka target. The mineralization at Eureka is quite different to the company's other deposits at Twin Hills and Ondundu, with its much higher gold grades associated with sulphide breccias and skarn alteration. The excitement is building within the team as we come to grips with what Eureka has to offer in terms of grade, scale and the potential for multiple deposits."

07:27 EST Telesat Holdings selects Aalyria's Spacetime for Lightspeed constellation - Telesat and Aalyria announced an Agreement to deploy Aalyria's Spacetime next-generation networking technology to organize the efficient flow of customer traffic over the Telesat Lightspeed Low Earth Orbit, LEO, satellite constellation. Telesat Lightspeed satellites will contain leading-edge technologies to focus and dynamically deliver reliable capacity to customers. To help achieve this mission, Telesat is leveraging Aalyria's unparalleled expertise in all-domain orchestration and management, ensuring seamless integration, optimal performance, and efficient operation of the Telesat Lightspeed network. Under the terms of the 10+-year agreement, Telesat will use Aalyria's Spacetime platform to find the most robust and reliable routing of customer data between any two points on earth through real-time analysis of millions of possible paths, autonomously evolving antenna link scheduling, dynamic network traffic routing, and spectrum resources based on changing network requirements. "Aalyria's Spacetime orchestration capabilities are a key enabler in achieving the lowest latency, highest availability and resiliency for meeting the committed information rates and service level agreements for our enterprise-class LEO services," stated Dave Wendling, Telesat's Chief Technical Officer. "Aalyria's expertise and heritage with Spacetime align perfectly with our vision for Telesat Lightspeed, and we are confident that this partnership will contribute to the success of this revolutionary network."

07:08 EST Teleflex's UroLift shows positive patient experience results in published study - Teleflex announced that a new peer-reviewed study in the Nature journal Prostate Cancer and Prostatic Diseases reinforces the position of the UroLift System as "the gold standard" in minimally invasive surgical treatment for benign prostatic hyperplasia - BPH -, or enlarged prostate. This first-of-its-kind study directly compares and analyzes outcomes in over 40,000 real-world BPH patients by applying a consistent definition of retreatment across the leading BPH treatments. Results suggest that within one year of BPH surgery, 1 in 20 patients may require retreatment regardless of whether they receive a transurethral resection of the prostate, GreenLight photoselective vaporization of the prostate, Rezm water vapor thermal therapy or UroLift System prostatic urethral lift; rates are not statistically different. At five years, retreatment was lowest for TURP and statistically similar between GreenLight PVP and the UroLift System. The retreatment rate for UroLift PUL is comparable to published controlled trial rates, thereby underscoring and demystifying the durability of the UroLift System. The study also provides a new way to assess and view complications following BPH surgery. At one-year procedural complications were lowest following the UroLift System - 15% - and highest following Rezm WVTT - 26% -. The average time to the first complication was the longest for the UroLift PUL.

06:56 EST Asensus Surgical sells Senhance Surgical System to distribution partner - Asensus Surgical announced that a Senhance Surgical System was sold to the company's distribution partner, and will be placed in a pediatric hospital in the Commonwealth of Independent States region.

06:48 EST Descartes Systems: AkkuShop.de achieves 300% increase in fulfillment efficiency - Descartes Systems announced that online battery technology and solutions retailer AkkuShop.de has increased fulfillment efficiency by 300% since introducing Descartes' ecommerce warehouse management system. The solution optimizes order fulfillment and warehouse management processes for online sales from the company's extensive product catalog of over 20,000 items, helping to ensure a high degree of customer satisfaction.

06:38 EST General Electric announces board of directors for GE Verona, GE Aerospace - GE announced the Boards of Directors for GE Vernova, the planned independent public company that will be created following its spin-off from GE, nd GE Aerospace. Reference Link

06:36 EST Clear Secure launches new lanes at Rhode Island T.F. Green International Airport - Clear Secure announced it is launching its identity verification technology at Rhode Island T.F. Green International Airport's, or PVD, main terminal, bringing frictionless and predictable travel experiences to Rhode Island. Clear's launch at PVD is expected to create 28 jobs and generate approximately $1.5M annually in local economic impact.

06:27 EST Roche subcutaneous injection of Tecentriq recommended by EU's CHMP - Roche announced that the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, has recommended the approval of subcutaneous Tecentriq. Tecentriq SC can be injected in approximately seven minutes, with most injections taking between four and eight minutes compared with 30-60 minutes for intravenous infusion, which can free up time for patients, healthcare teams and caregivers. The CHMP recommended Tecentriq SC for all indications in which Tecentriq IV has been previously approved, including certain types of lung, liver, bladder and breast cancer. A final decision on its approval is expected from the European Commission in the near future.

06:21 EST AstraZeneca says PACIFIC-2 trial did not hit primary PFS endpoint - The PACIFIC-2 Phase III trial for Imfinzi concurrently administered with chemoradiotherapy did not achieve statistical significance for the primary endpoint of progression-free survival, or PFS, versus CRT alone for the treatment of patients with unresectable, Stage III non-small cell lung cancer, or NSCLC, AstraZeneca announced. Initial analysis of the safety and tolerability for Imfinzi and CRT in this patient population showed that the profiles were broadly consistent with the known profiles of these treatments, although there was an increased rate of infection observed during the concurrent treatment period in the experimental arm. Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca, said: "Our goal with the PACIFIC-2 trial was to address a remaining unmet need for patients in this setting by introducing immunotherapy even earlier and concurrently administering Imfinzi with chemoradiotherapy. While today's results did not reach statistical significance, we will learn from this trial and we remain committed to improving patient outcomes by expanding the benefit of immunotherapy to lung cancer patients across treatment settings."

06:15 EST Emeren signs SPA of a 29 MWp solar PV portfolio in Spain to Rubis Photosol - Emeren announced the successful signing SPA of a 29 MWp solar PV portfolio in Spain to Rubis Photosol, one of France's photovoltaic electricity producers. This transaction was facilitated through the European Solar Energy Development JV, a collaborative venture established between Emeren and Eiffel Investment Group, a renowned French asset manager and Finergreen, Emeren's consultant partner who supported on the transaction. The 29 MWp portfolio comprises three late-stage projects located in the Municipality of Algorfa, Alicante, Spain, in an advanced phase of obtaining the Administrative Authorisation for Construction, or AAC. These projects are expected to be operational during the second half of 2025 and equipped with PV solar trackers, projected to generate approximately 57,000 MWh of clean energy, capable of powering around 20,000 households. The JV, inaugurated in early 2021, leverages Emeren Group's extensive experience in solar PV development in Europe and the financial resources of Eiffel Investment Group, which play a pivotal role throughout the project lifecycle.

06:05 EST Radware signs agreement with European telecom provider - Radware announced it signed an agreement with a leading European telecom and managed security service provider. Ranking among its country's top four largest telecoms based on revenue, the carrier will utilize Radware's behavioral-based DDoS protection to strengthen the network security for its data center infrastructure and customers. The carrier provides telephony, mobile, and internet TV for millions of businesses and households and supports one of the most extensive broadband infrastructures in Europe. To increase its DDoS defenses against new threat vectors and expand its security portfolio, the carrier replaced its existing DDoS mitigation solution with Radware's DefensePro X DDoS Protection platform and Cyber Controller.

05:53 EST Boeing, Oman Air announce order and delivery of 737-800 Converted Freight - Boeing and Oman Air announced an order and delivery of the operator's first 737-800 Boeing Converted Freighter, or BCF. The order is the first dedicated cargo aircraft for the Muscat-based carrier. Oman Air Cargo saw its cargo volume increase 42% during the first half of 2023, compared to the same period in 2022, driven primarily by capacity expansion across its passenger airplane fleet. With the ability to carry up to 23.9 tons of freight at a range of 3,750 km, the 737-800BCF will contribute to continued capacity growth.

05:48 EST Addex Therapeutics completes recruitment of patients in ADX71149 - Addex Therapeutics (ADXN) announced that the last patient has been randomized in Cohort 2 of the ADX71149 Phase 2 epilepsy clinical study. Results evaluating the efficacy, safety and tolerability of ADX71149 in combination with levetiracetam or brivaracetam from patient Cohorts 1 and Cohort 2 are anticipated for the second quarter of 2024. The primary efficacy endpoint of this study is time to baseline monthly seizure count. The trial is being conducted in collaboration with Janssen Pharmaceuticals, a Johnson & Johnson (JNJ) company. As previously announced on May 10, an independent Interim Review Committee, or IRC, convened by Janssen recommended to continue the study following review of unblinded data from Part 1 of patient Cohort 1.

05:43 EST PureTech Health announces LYT-300 achieves primary endpoint - PureTech Health announced topline results from its Phase 2a, randomized, placebo-controlled, proof-of-concept trial of LYT-300. The trial was designed to evaluate the salivary cortisol response in the Trier Social Stress Test, or TSST, a validated clinical model of anxiety in healthy volunteers. Oral administration of LYT-300 achieved the trial's primary endpoint of a statistically significant reduction versus placebo in the increase from baseline to peak levels of the stress hormone salivary cortisol. The LYT-300 treatment effect size versus placebo was 0.72, as measured by Cohen's d, which is one of the most common ways to measure effect size. LYT-300 showed a similar effect size to previously observed results for alprazolam, a benzodiazepine drug indicated for treatment of anxiety disorders, when assessed following the TSST procedure. An increase in cortisol levels after the TSST is a physiological response and an objective biomarker of acute stress. Eighty healthy volunteers were randomized and treated with either LYT-300 or placebo in a 1:1 ratio. LYT-300 was well tolerated, with all treatment-related adverse events transient, mild or moderate and consistent with the known pharmacology profile of allopregnanolone. Additional data from the study will be presented in a scientific forum. As part of an overall development strategy in anxiety-related indications, PureTech will be conducting additional studies in 2024. Further guidance will be provided regarding 2024 catalysts associated with the planned studies.

05:30 EST Absci, Almirall enter drug discovery partnership - Almirall and Absci announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci's Integrated Drug Creation platform with Almirall's dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation. The partnership represents Almirall's first de novo AI drug collaboration, and it comes only months after Absci announced it could design and validate de novo therapeutic antibodies using its 'zero-shot' generative AI. Under the terms of the partnership, Absci will apply its de novo generative AI technology to create and commercialize therapeutic candidates for two dermatological targets. In addition to product royalties, Absci is eligible to receive up to approximately $650M in upfront fees, R&D, and post-approval milestone payments across the two programs if all milestones are successfully completed.

05:23 EST SCAT Airlines orders seven 737-8 airplanes from Boeing - Boeing and SCAT Airlines announced an order for seven 737-8 airplanes to expand its 737 MAX fleet. The latest order will nearly double SCAT's 737 fleet as the airline looks to open new routes to European destinations. Based in hymkent, Kazakhstan, SCAT serves a network of domestic and international destinations in the Commonwealth of Independent States and Central Asia. SCAT was the first airline in Central Asia to fly the 737 MAX and currently operates three 737-8 and five 737-9 airplanes. This order was previously unidentified on the Boeing Orders & Deliveries website.

05:12 EST AerCap acquires five General Electric GE90-115B engines from Sanad - AerCap announced the successful acquisition of five General Electric GE90-115B engines from Sanad, the global aerospace engineering and leasing solutions leader wholly owned by Abu Dhabi's sovereign investor Mubadala Investment Company PJSC. This significant transaction was announced at the Dubai Airshow 2023.